el-Din M M, Malik K U
Department of Pharmacology, College of Medicine, University of Tennessee Center for the Health Sciences, Memphis.
J Pharmacol Exp Ther. 1987 Oct;243(1):76-85.
We have investigated the mechanism by which renal nerve stimulation (RNS), veratridine (Vt) and KCl promote release of norepinephrine in the isolated rat kidney perfused with Tyrode's solution and prelabeled with [3H]norepinephrine by examining the overflow of tritium elicited by these stimuli during 1) extracellular Ca++ depletion, 2) alterations in extracellular Na+ concentration and 3) administration of tetrodotoxin, amiloride, LiCl and calcium channel blockers. RNS (1-4 Hz), Vt (15-90 nmol) and KCl (150-500 mumol) produced renal vasoconstriction and enhanced the tritium overflow in a frequency- and concentration-dependent manner, respectively. Omission of Ca++ (1.8 mM) from the perfusion fluid abolished the renal vasoconstriction and the increase in tritium overflow elicited by RNA and KCl and substantially reduced that caused by Vt. Lowering the Na+ concentration in the perfusion medium (from 150 to 25 mM) reduced the overflow of tritium and the renal vasoconstriction caused by RNS (2 Hz) or Vt (45 nmol); the increase in tritium overflow in response to these stimuli was positively correlated with extracellular Na+ (25-150 mM). In contrast, KCl-induced tritium overflow was negatively correlated with extracellular Na+ concentration. Tetrodotoxin (0.3 microM) abolished the effect of RNS and Vt, but not that of KCl, to increase overflow of tritium and to produce renal vasoconstriction. Administration of amiloride (180 microM) enhanced the overflow of tritium but attenuated the associated renal vasoconstriction produced by RNS, Vt and KCl. Replacement of NaCl (75 mM) with equimolar concentration of LiCl enhanced the overflow of tritium elicited by RNS, Vt and KCl; the associated renal vasoconstriction remained unaltered. Administration of Ca++ channel blocker, flunarizine (2 microM), but not diltiazem (6 microM) or nifedipine (1.4 microM), inhibited RNS-, Vt- and KCl-induced overflow of tritium; nifedipine enhanced whereas diltiazem failed to alter tritium overflow elicited by these stimuli. The renal vasoconstriction produced by RNS, Vt and KCl was inhibited by diltiazem and nifedipine, as well as by flunarizine. These data suggest that RNS, Vt and KCl enhance release of the adrenergic transmitter by promoting influx of Ca++ into the nerve terminal, not by Na+-Ca++ exchange transport process, but rather through specific Ca++ channels that are distinct from those located in the vascular smooth muscle.
我们研究了肾神经刺激(RNS)、藜芦碱(Vt)和氯化钾促进预先用[3H]去甲肾上腺素标记并灌注台氏液的离体大鼠肾脏释放去甲肾上腺素的机制,通过在以下情况中检测这些刺激引起的氚溢出:1)细胞外Ca++耗竭;2)细胞外Na+浓度改变;3)给予河豚毒素、阿米洛利、LiCl和钙通道阻滞剂。RNS(1 - 4Hz)、Vt(15 - 90nmol)和KCl(150 - 500μmol)分别以频率和浓度依赖性方式产生肾血管收缩并增强氚溢出。灌注液中去除Ca++(1.8mM)消除了RNS和KCl引起的肾血管收缩及氚溢出增加,并显著降低了Vt引起的上述效应。将灌注培养基中的Na+浓度降低(从150mM降至25mM)减少了RNS(2Hz)或Vt(45nmol)引起的氚溢出及肾血管收缩;对这些刺激的氚溢出增加与细胞外Na+(25 - 150mM)呈正相关。相反,KCl诱导的氚溢出与细胞外Na+浓度呈负相关。河豚毒素(0.3μM)消除了RNS和Vt增加氚溢出及产生肾血管收缩的作用,但对KCl无此作用。给予阿米洛利(180μM)增强了氚溢出,但减弱了RNS、Vt和KCl产生的相关肾血管收缩。用等摩尔浓度的LiCl替代NaCl(75mM)增强了RNS、Vt和KCl引起的氚溢出;相关的肾血管收缩未改变。给予Ca++通道阻滞剂氟桂利嗪(2μM),而非地尔硫䓬(6μM)或硝苯地平(1.4μM),抑制了RNS、Vt和KCl诱导的氚溢出;硝苯地平增强了而地尔硫䓬未能改变这些刺激引起的氚溢出。RNS、Vt和KCl产生的肾血管收缩被地尔硫䓬、硝苯地平以及氟桂利嗪抑制。这些数据表明,RNS、Vt和KCl通过促进Ca++流入神经末梢来增强肾上腺素能递质的释放,不是通过Na+-Ca++交换转运过程,而是通过与血管平滑肌中不同的特定Ca++通道。